Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2019 Mar;22(1):41-51.
doi: 10.1007/s40477-018-0343-0. Epub 2018 Dec 22.

SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease

Gianpaolo Vidili  1 , Ilario De Sio  2 , Mirko D'Onofrio  3 , Paoletta Mirk  4 , Michele Bertolotto  5 , Cosima Schiavone  6 ; SIUMB experts committee
Collaborators, Affiliations
Practice Guideline

SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease

Gianpaolo Vidili et al. J Ultrasound. 2019 Mar.

Abstract

The present document describes the SIUMB (Italian Society of Ultrasound in Medicine and Biology) guidelines for the use of ultrasound in the management of focal liver disease. The aim of the paper is to provide a clinical practice guideline for Italian physicians who are approaching the ultrasound study of a focal liver lesion. In particular, these guidelines provide simple indications, recommendations and general practice advices for the correct use of contrast-enhanced ultrasound (CEUS) in this scenario. They represent the SIUMB position of the ultrasound role in the diagnostic flow charts of the principal focal liver lesions, and are in agreement with other, previously published national and international guidelines.

Keywords: Cholangiocellular carcinoma; Contrast enhanced ultrasound; Focal nodular hyperplasia; Hemangioma; Hepatocellular carcinoma; Metastasis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

    1. Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med. 2004;25:249–256. doi: 10.1055/s-2004-813245. - DOI - PubMed
    1. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultraschall Med. 2008;29:28–44. doi: 10.1055/s-2007-963785. - DOI - PubMed
    1. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34:11–29. doi: 10.1055/s-0033-1335890. - DOI - PubMed
    1. Bruix J, Sherman M, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022. doi: 10.1002/hep.24199. - DOI - PMC - PubMed
    1. Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236. doi: 10.1002/hep.20933. - DOI - PubMed

Publication types